Letter: Changes in dermoscopic features in superficial basal cell carcinomas treated with imiquimod.
Micantonio
Tamara
T
Fargnoli
Maria Concetta
MC
Piccolo
Domenico
D
Peris
Ketty
K
D000368:Aged; D000369:Aged, 80 and over; D000634:Aminoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology*; D046169:Dermoscopy / Q000379:methods*; D016903:Drug Monitoring; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006801:Humans; D000077271:Imiquimod; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D012883:Skin Ulcer / Q000139:chemically induced
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D000077271:Imiquimod